Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Other Working Capital Changes: 2019-2024

Historic Other Working Capital Changes for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to -$3.7 million.

  • GeneDx Holdings' Other Working Capital Changes fell 142.26% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year decrease of 204.90%. This contributed to the annual value of -$3.7 million for FY2024, which is 247.35% down from last year.
  • As of FY2024, GeneDx Holdings' Other Working Capital Changes stood at -$3.7 million, which was down 247.35% from $2.5 million recorded in FY2023.
  • GeneDx Holdings' 5-year Other Working Capital Changes high stood at $14.2 million for FY2021, and its period low was -$3.7 million during FY2024.
  • Moreover, its 3-year median value for Other Working Capital Changes was $2.5 million (2023), whereas its average is $2.4 million.
  • Per our database at Business Quant, GeneDx Holdings' Other Working Capital Changes soared by 670.46% in 2021 and then crashed by 247.35% in 2024.
  • GeneDx Holdings' Other Working Capital Changes (Yearly) stood at -$2.5 million in 2020, then surged by 670.46% to $14.2 million in 2021, then plummeted by 40.67% to $8.5 million in 2022, then tumbled by 70.12% to $2.5 million in 2023, then crashed by 247.35% to -$3.7 million in 2024.